July 12, 2011 —Crizotinib, a new targeted drug aimed at certain patients with nonsmall-cell lung cancer (NSCLC), is expected to be approved before the end of the year. The drug targets an ALK ...

Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries Most crizotinib-treated patients with anaplastic lymphoma kinase gene (ALK)–rearranged ...

Discover comprehensive details about Crizotinib, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

October 27, 2010 — Striking activity reported for the oral investigational drug crizotinib (Pfizer) in tumors that harbor a specific mutant protein has prompted a New England Journal of Medicine ...

Doctors are reluctant to read too much into promising results from small clinical trials of cancer drugs. No point getting excited when so often drugs don’t look as hot after being tested in a larger ...

Imatinib-Associated Tumor Lysis Syndrome in a Patient With Myeloid Neoplasm With Eosinophilia and PDGFRA Rearrangement: A Case Report and Review of the Literature A 56-year-old man presented with ...

Now a new drug called ceritinib appears to be effective against advanced ALK-positive non-small cell lung cancer, both in tumors that have become resistant to crizotinib and in those never treated ...

(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a synthetic lethality focused precision medicine oncology company, announced Monday that it has entered into additional clinical trial collaboration and ...

Crizotinib is effective in shrinking tumors in patients with anaplastic lymphoma receptor tyrosine kinase positive non-small cell lung cancer, a cancer commonly found in people who never smoked, and ...

Evidence-based recommendations on crizotinib (Xalkori) for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer in adults. We found nothing new that affects the ...

The appraisal committee considered evidence submitted by Pfizer and a review of this submission by the evidence review group (ERG). See the committee papers for full details of the evidence. The ...